Indeed, hydroxytyrosol has been shown to inhibit pro-inflammatory cytokine expression in LPS-stimulated human monocytes [55], and catechins modulate the NF-κB and MAPK signalling pathways in models of inflammatory bowel disease [56]. The gene discussed is NFKB1; the disease is inflammatory bowel disease.